AMLODIPINE AND OLMESARTAN MEDOXOMIL

Generic: AMLODIPINE AND OLMESARTAN MEDOXOMIL

Ascend LaboratoriesManufacturer
ORALRoute
AMLODIPINE BESYLATEActive Substance
2017-08-14Original Approval

AMLODIPINE AND OLMESARTAN MEDOXOMIL is FDA application ANDA209042, sponsored by ALKEM LABS LTD. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Top Reported Reactions

1
DRUG INEFFECTIVE
23 reports
2
HYPOTENSION
15 reports
3
DIARRHOEA
14 reports
4
ACUTE KIDNEY INJURY
13 reports
5
DIZZINESS
12 reports
6
HYPERTENSION
11 reports
7
INTENTIONAL OVERDOSE
11 reports
8
SPRUE-LIKE ENTEROPATHY
11 reports
9
TOXICITY TO VARIOUS AGENTS
10 reports
10
BLOOD PRESSURE INCREASED
9 reports